SCHEMBL2909588

SCHEMBL2909588

COc1ccc(CCN2C(=O)N(CC3CC3)C(=O)C23CCN(c2cccc(CC(=O)OC(C)(C)C)c2)CC3)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 2/20 0.37
BACE1 P56817 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37
HTR1A P08908 1/20 0.37
HTR7 P34969 1/20 0.37
HTR6 P50406 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 4/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TP53 P04637 2/20 0.35
MAPT P10636 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MMP1 P03956 1/20 0.34
MMP9 P14780 1/20 0.34
MMP13 P45452 1/20 0.34
ALDH1A1 P00352 2/20 0.34
USP2 O75604 1/20 0.34
CYP1A2 P05177 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2916834 0.92 HTR1A (0.39) MCHR1BACE1FFAR4HTR1AHTR7
SCHEMBL2912597 0.90 FFAR4 (0.43) MCHR1FFAR4HTR1AHTR7HTR6
SCHEMBL2909327 0.88 OPRM1 (0.36) SMN1; SMN2MAPTMEN1KMT2AALDH1A1
SCHEMBL2917453 0.87 FFAR4 (0.42) MCHR1FFAR4HTR1AHTR7HTR6
SCHEMBL2917223 0.85 CHRM4 (0.43) FFAR4
SCHEMBL2915308 0.82 HTR1A (0.43) MCHR1FFAR4HTR1AHTR7HTR6
SCHEMBL2913320 0.81 HTR1A (0.39) HTR1AHTR7HTR6L3MBTL1LMNA
SCHEMBL13212951 0.80 HTR1A (0.38) HTR1AHTR7HTR6L3MBTL1LMNA
SCHEMBL2912440 0.79 HTR1A (0.41) FFAR4HTR1AHTR7HTR6LMNA
SCHEMBL2916528 0.79 HTR1A (0.43) MCHR1FFAR4HTR1AHTR7HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979355-B1 SPIRO IMIDAZOLE DERIVATIVES AS PPAR MODULATORS IRM LLC (BM) 2010-08-18 EP disclosed
US-20090137610-A1 SPIRO IMIDOZOLE DERIVATIVES AS PPAR MODULATORS IRM LLC (BM) 2009-05-28 US disclosed
EP-1979355-A1 SPIRO IMIDAZOLE DERIVATIVES AS PPAR MODULATORS IRM LLC (BM) 2008-10-15 EP disclosed
WO-2007087448-A1 SPIRO IMIDAZOLE DERIVATIVES AS PPAR MODULATORS IRM LLC (BM) 2007-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137610-A1 SPIRO IMIDOZOLE DERIVATIVES AS PPAR MODULATORS PPARD, PPARG, PPARA MCHR1 4317/4885BACE1 4599/4885FFAR4 207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.